Skip to content

Relevant research on iliofascial space block for postoperative analgesia after arthroscopic anterior cruciate ligament reconstruction

Relevant research on iliofascial space block for postoperative analgesia after arthroscopic anterior cruciate ligament reconstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122695
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

G+ F per group:Under general anesthesia induction, an ultrasound-guided iliac fascia compartment block was performed on the affected side, with 30 ml of 0.25% ropivacaine hydrochloride used for the bl
G+ F post group:General anesthesia, after the surgery under ultrasound guidance, an iliac fascia plane block was performed on the affected side, with 30ml of 0.25% ropivacaine hydrochloride used for t
G+ F per + Dexa group:After general anesthesia induction, an ultrasound-guided iliac fascia compartment block was performed on the affected side. The block medication was 0.25% ropivacaine hydrochlor
G+ F post +Dexa group:Under general anesthesia, after the end of the surgery, an ultrasound-guided fascia iliaca compartment block on the affected side was performed. The block medication was 0.25% ro

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria and surgical indications for anterior cruciate ligament injury as outlined in the "Guidelines for Anterior Cruciate Ligament Reconstruction under Arthroscopy," and is confirmed by imaging examination; 2. Age between 18 and 60 years; 3. American Society of Anesthesiologists (ASA) classification I to II; 4. Able to understand the research steps and the application of various scales, understand the specific content of the informed consent form, and make a voluntary commitment to participate in the study;

Exclusion criteria

Exclusion criteria: 1. Combined severe dysfunction of organs such as the heart, liver, lungs, and kidneys, systemic metabolic, mental, and nervous system diseases; diseases accompanied by coagulation disorders and those affecting test results; being in the lactation or pregnancy period. 2. Individuals allergic to the anesthetic drugs used in this study. 3. Those who refuse to receive postoperative analgesia.

Design outcomes

Primary

MeasureTime frame
Visual analogue scoring;

Secondary

MeasureTime frame
The incidence of moderate to severe postoperative pain;Motor function indicators;Analgesic pumps and drug usage indicators;Medical satisfaction indicator: The satisfaction of surgeons with patients;Sleep quality score;Adverse reaction indicators;

Countries

China

Contacts

Public ContactAn Wenjuan; Zhang Lingyun

Gansu Provincial Hospital of Traditional Chinese Medicine

zhangly8848@163.com+86 155 3085 6221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026